drugset / Trial / NCT05894694

Survival Benefit of Compound Kushen Injection in the Treatment of Advanced Colorectal Cancer

NCT05894694

RandomizedParallel-groupOpen-labelTreatment

Summary

To clarify the effectiveness and safety of compound kushen injection in the treatment of advanced colorectal cancer.

Timeline

Start
2023-09-27
Primary completion
2025-12-30
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Compound Kushen injection Traditional medicine (herbal / TCM) 20 ml Intravenous
Background Bevacizumab Monoclonal antibody
Background Cetuximab Monoclonal antibody

Indications